Sarcolemma instability during mechanical activity in large myd cardiac myocytes with loss of dystroglycan extracellular matrix receptor function

Human Molecular Genetics

Volumn 20, Issue 17, 2011, Pages 3346-3355

  Kabaeva, Zhyldyz ^a   Meekhof, Kailyn E ^a   Michele, Daniel E ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DYSTROGLYCAN; GLYCOSYLTRANSFERASE; IMMUNOGLOBULIN G; LAMININ; LAMININ RECEPTOR; PROPIDIUM IODIDE; PROTEIN LARGE; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CELL ADHESION; CELL CULTURE; CELL DAMAGE; CELL STRETCHING; CELL VIABILITY; CELLULAR PARAMETERS; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HEART MUSCLE CELL; IMMUNOFLUORESCENCE TEST; MOUSE; MOUSE MUTANT; MUSCULAR DYSTROPHY; NONHUMAN; NULL ALLELE; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; SARCOLEMMA; SARCOLEMMA STABILITY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL ADHESION; CELLS, CULTURED; DYSTROGLYCANS; MICE; MYOCYTES, CARDIAC; RECEPTORS, CELL SURFACE; SARCOLEMMA;

MUS;

EID: 80051696437     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr240     Document Type: Article

References (58)

1. Kirchmann, C., Kececioglu, D., Korinthenberg, R. and Dittrich, S. (2005) Echocardiographic and electrocardiographic ndings of cardiomyopathy in Duchenne and Becker-Kiener muscular dystrophies. Pediatr. Cardiol., 26, 66-72.
2. Saito, M., Kawai, H., Akaike, M., Adachi, K., Nishida, Y. and Saito, S. (1996) Cardiac dysfunction with Becker muscular dystrophy. Am. Heart J., 132, 642-647.
3. Tsubata, S., Bowles, K.R., Vatta, M., Zintz, C., Titus, J., Muhonen, L., Bowles, N.E. and Towbin, J.A. (2000) Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J. Clin. Invest., 106, 655-662.
4. Nakanishi, T., Sakauchi, M., Kaneda, Y., Tomimatsu, H., Saito, K., Nakazawa, M. and Osawa, M. (2006) Cardiac involvement in Fukuyama-type congenital muscular dystrophy. Pediatrics, 117, e1187-e1192.
5. Michele, D.E., Barresi, R., Kanagawa, M., Saito, F., Cohn, R.D., Satz, J.S., Dollar, J., Nishino, I., Kelley, R.I., Somer, H. et al. (2002) Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature, 418, 417-422.
6. (2008) Gene table of monogenic neuromuscular disorders (nuclear genome only). Neuromuscul. Disord., 18, 101-129.
7. Barresi, R., Michele, D.E., Kanagawa, M., Harper, H.A., Dovico, S.A., Satz, J.S., Moore, S.A., Zhang, W., Schachter, H., Dumanski, J.P. et al. (2004) LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies. Nat. Med., 10, 696-703.
8. Kanagawa, M., Saito, F., Kunz, S., Yoshida-Moriguchi, T., Barresi, R., Kobayashi, Y.M., Muschler, J., Dumanski, J.P., Michele, D.E., Oldstone, M.B. et al. (2004) Molecular recognition by LARGE is essential for expression of functional dystroglycan. Cell, 117, 953-964.
9. Grewal, P.K., Holzfeind, P.J., Bittner, R.E. and Hewitt, J.E. (2001) Mutant glycosyltransferase and altered glycosylation of alpha-dystroglycan in the myodystrophy mouse. Nat. Genet., 28, 151-154.
10. Grewal, P.K., McLaughlan, J.M., Moore, C.J., Browning, C.A. and Hewitt, J.E. (2005) Characterization of the LARGE family of putative glycosyltransferases associated with dystroglycanopathies. Glycobiology, 15, 912-923.
11. Longman, C., Brockington, M., Torelli, S., Jimenez-Mallebrera, C., Kennedy, C., Khalil, N., Feng, L., Saran, R.K., Voit, T., Merlini, L. et al. (2003) Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Hum. Mol. Genet., 12, 2853-2861.
12. Holzfeind, P.J., Grewal, P.K., Reitsamer, H.A., Kechvar, J., Lassmann, H., Hoeger, H., Hewitt, J.E. and Bittner, R.E. (2002) Skeletal, cardiac and tongue muscle pathology, defective retinal transmission, and neuronal migration defects in the Large(myd) mouse denes a natural model for glycosylation-decient muscle-eye-brain disorders. Hum. Mol. Genet., 11, 2673-2687.
13. Hara, Y., Balci-Hayta, B., Yoshida-Moriguchi, T., Kanagawa, M., Beltran-Valero de Bernabe, D., Gundesli, H., Willer, T., Satz, J.S., Crawford, R.W., Burden, S.J. et al. (2011) A dystroglycan mutation associated with limb-girdle muscular dystrophy. N. Engl. J. Med., 364, 939-946.
14. Ervasti, J.M. and Campbell, K.P. (1993) A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol., 122, 809-823.
15. Ibraghimov-Beskrovnaya, O., Ervasti, J.M., Leveille, C.J., Slaughter, C.A., Sernett, S.W. and Campbell, K.P. (1992) Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature, 355, 696-702.
16. Sugita, S., Saito, F., Tang, J., Satz, J., Campbell, K. and Sudhof, T.C. (2001) A stoichiometric complex of neurexins and dystroglycan in brain. J. Cell Biol., 154, 435-445.
17. Gee, S.H., Montanaro, F., Lindenbaum, M.H. and Carbonetto, S. (1994) Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor. Cell, 77, 675-686.
18. Michele, D.E., Kabaeva, Z., Davis, S.L., Weiss, R.M. and Campbell, K.P. (2009) Dystroglycan matrix receptor function in cardiac myocytes is important for limiting activity-induced myocardial damage. Circ. Res., 105, 984-993.
19. Ervasti, J.M., Ohlendieck, K., Kahl, S.D., Gaver, M.G. and Campbell, K.P. (1990) Deciency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature, 345, 315-319.
20. Durbeej, M., Cohn, R.D., Hrstka, R.F., Moore, S.A., Allamand, V., Davidson, B.L., Williamson, R.A. and Campbell, K.P. (2000) Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E. Mol. Cell, 5, 141-151.
21. Matsumura, K., Chiba, A., Yamada, H., Fukuta-Ohi, H., Fujita, S., Endo, T., Kobata, A., Anderson, L.V., Kanazawa, I., Campbell, K.P. et al. (1997) A role of dystroglycan in schwannoma cell adhesion to laminin. J. Biol. Chem., 272, 13904-13910.
22. de Bernabe, D.B., Inamori, K., Yoshida-Moriguchi, T., Weydert, C.J., Harper, H.A., Willer, T., Henry, M.D. and Campbell, K.P. (2009) Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE. J. Biol. Chem., 284, 11279-11284.
23. Sgambato, A., Migaldi, M., Montanari, M., Camerini, A., Brancaccio, A., Rossi, G., Cangiano, R., Losasso, C., Capelli, G., Trentini, G.P. et al. (2003) Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression. Am. J. Pathol., 162, 849-860.
24. Colognato, H., Winkelmann, D.A. and Yurchenco, P.D. (1999) Laminin polymerization induces a receptor-cytoskeleton network. J. Cell Biol., 145, 619-631.
25. McKee, K.K., Harrison, D., Capizzi, S. and Yurchenco, P.D. (2007) Role of laminin terminal globular domains in basement membrane assembly. J. Biol. Chem., 282, 21437-21447.
26. Henry, M.D. and Campbell, K.P. (1998) A role for dystroglycan in basement membrane assembly. Cell, 95, 859-870.
27. Williamson, R.A., Henry, M.D., Daniels, K.J., Hrstka, R.F., Lee, J.C., Sunada, Y., Ibraghimov-Beskrovnaya, O. and Campbell, K.P. (1997) Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice. Hum. Mol. Genet., 6, 831-841.
28. Poppe, M., Cree, L., Bourke, J., Eagle, M., Anderson, L.V., Birchall, D., Brockington, M., Buddles, M., Busby, M., Muntoni, F. et al. (2003) The phenotype of limb-girdle muscular dystrophy type 2I. Neurology, 60, 1246-1251.
29. Poppe, M., Bourke, J., Eagle, M., Frosk, P., Wrogemann, K., Greenberg, C., Muntoni, F., Voit, T., Straub, V., Hilton-Jones, D. et al. (2004) Cardiac and respiratory failure in limb-girdle muscular dystrophy 2I. Ann. Neurol., 56, 738-741.
30. Boito, C.A., Melacini, P., Vianello, A., Prandini, P., Gavassini, B.F., Bagattin, A., Siciliano, G., Angelini, C. and Pegoraro, E. (2005) Clinical and molecular characterization of patients with limb-girdle muscular dystrophy type 2I. Arch. Neurol., 62, 1894-1899.
31. Brockington, M., Blake, D.J., Prandini, P., Brown, S.C., Torelli, S., Benson, M.A., Ponting, C.P., Estournet, B., Romero, N.B., Mercuri, E. et al. (2001) Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deciency and abnormal glycosylation of alpha-dystroglycan. Am. J. Hum. Genet., 69, 1198-1209.
32. Brockington, M., Yuva, Y., Prandini, P., Brown, S.C., Torelli, S., Benson, M.A., Herrmann, R., Anderson, L.V., Bashir, R., Burgunder, J.M. et al. (2001) Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum. Mol. Genet., 10, 2851-2859.
33. Wahbi, K., Meune, C., Hamouda el, H., Stojkovic, T., Laforet, P., Becane, H.M., Eymard, B. and Duboc, D. (2008) Cardiac assessment of limb-girdle muscular dystrophy 2I patients: an echography, Holter ECG and magnetic resonance imaging study. Neuromuscul. Disord., 18, 650-655.
34. D'Amico, A., Petrini, S., Parisi, F., Tessa, A., Francalanci, P., Grutter, G., Santorelli, F.M. and Bertini, E. (2008) Heart transplantation in a child with LGMD2I presenting as isolated dilated cardiomyopathy. Neuromuscul. Disord., 18, 153-155.
35. Murakami, T., Hayashi, Y.K., Noguchi, S., Ogawa, M., Nonaka, I., Tanabe, Y., Ogino, M., Takada, F., Eriguchi, M., Kotooka, N. et al. (2006) Fukutin gene mutations cause dilated cardiomyopathy with minimal muscle weakness. Ann. Neurol., 60, 597-602.
36. Wooddell, C.I., Zhang, G., Grifn, J.B., Hegge, J.O., Huss, T. and Wolff, J.A. (2010) Use of Evans blue dye to compare limb muscles in exercised young and old mdx mice. Muscle Nerve, 41, 487-499.
37. Li, S., Harrison, D., Carbonetto, S., Fassler, R., Smyth, N., Edgar, D. and Yurchenco, P.D. (2002) Matrix assembly, regulation, and survival functions of laminin and its receptors in embryonic stem cell differentiation. J. Cell Biol., 157, 1279-1290.
38. Petrof, B.J., Shrager, J.B., Stedman, H.H., Kelly, A.M. and Sweeney, H.L. (1993) Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl Acad. Sci. USA, 90, 3710-3714.
39. Boutonnat, J., Barbier, M., Muirhead, K., Mousseau, M., Ronot, X. and Seigneurin, D. (1999) Optimized uorescent probe combinations for evaluation of proliferation and necrosis in anthracycline-treated leukaemic cell lines. Cell Prolif., 32, 203-213.
40. Lundgren, E., Terracio, L. and Borg, T.K. (1985) Adhesion of cardiac myocytes to extracellular matrix components. Basic Res. Cardiol., 80(Suppl. 1), 69-74.
41. Yurchenco, P.D. and Patton, B.L. (2009) Developmental and pathogenic mechanisms of basement membrane assembly. Curr. Pharm. Des., 15, 1277-1294.
42. Boppart, M.D., Burkin, D.J. and Kaufman, S.J. (2006) Alpha7beta1-integrin regulates mechanotransduction and prevents skeletal muscle injury. Am. J. Physiol. Cell Physiol., 290, C1660-C1665.
43. Burkin, D.J., Wallace, G.Q., Nicol, K.J., Kaufman, D.J. and Kaufman, S.J. (2001) Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice. J. Cell Biol., 152, 1207-1218.
44. Yang, W., Lin, Q., Guan, J.L. and Cerione, R.A. (1999) Activation of the Cdc42-associated tyrosine kinase-2 (ACK-2) by cell adhesion via integrin beta1. J. Biol. Chem., 274, 8524-8530.
45. Sanes, J.R. (2003) The basement membrane/basal lamina of skeletal muscle. J. Biol. Chem., 278, 12601-12604.
46. Hayashi, Y.K., Engvall, E., Arikawa-Hirasawa, E., Goto, K., Koga, R., Nonaka, I., Sugita, H. and Arahata, K. (1993) Abnormal localization of laminin subunits in muscular dystrophies. J. Neurol. Sci., 119, 53-64.
47. Rybakova, I.N., Patel, J.R. and Ervasti, J.M. (2000) The dystrophin complex forms a mechanically strong link between the sarcolemma and costameric actin. J. Cell Biol., 150, 1209-1214.
48. Ervasti, J.M. (2003) Costameres: the Achilles' heel of Herculean muscle. J. Biol. Chem., 278, 13591-13594.
49. Ramaswamy, K.S., Palmer, M.L., van der Meulen, J.H., Renoux, A., Kostrominova, T.Y., Michele, D.E. and Faulkner, J.A. (2011) Lateral transmission of force is impaired in skeletal muscles of dystrophic mice and very old rats. J. Physiol., 589, 1195-1208.
50. Straub, V., Rafael, J.A., Chamberlain, J.S. and Campbell, K.P. (1997) Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J. Cell Biol., 139, 375-385.
51. Wehling, M., Spencer, M.J. and Tidball, J.G. (2001) A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J. Cell Biol., 155, 123-131.
52. Mariol, M.C. and Segalat, L. (2001) Muscular degeneration in the absence of dystrophin is a calcium-dependent process. Curr. Biol., 11, 1691-1694.
53. Coral-Vazquez, R., Cohn, R.D., Moore, S.A., Hill, J.A., Weiss, R.M., Davisson, R.L., Straub, V., Barresi, R., Bansal, D., Hrstka, R.F. et al. (1999) Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell, 98, 465-474.
54. Yasuda, S., Townsend, D., Michele, D.E., Favre, E.G., Day, S.M. and Metzger, J.M. (2005) Dystrophic heart failure blocked by membrane sealant poloxamer. Nature, 436, 1025-1029.
55. Villalta, S.A., Rinaldi, C., Deng, B., Liu, G., Fedor, B. and Tidball, J.G. (2011) Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype. Hum. Mol. Genet., 20, 790-805.
56. Spurney, C.F., Sali, A., Guerron, A.D., Iantorno, M., Yu, Q., Gordish-Dressman, H., Rayavarapu, S., van der Meulen, J., Hoffman, E.P. and Nagaraju, K. (2011) Losartan decreases cardiac muscle brosis and improves cardiac function in dystrophin-decient mdx mice. J. Cardiovasc. Pharmacol. Ther., 16, 87-95.
57. Institute for Laboratory Animal Research. National Research Council. (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington, DC.
58. Kabaeva, Z., Zhao, M. and Michele, D.E. (2008) Blebbistatin extends culture life of adult mouse cardiac myocytes and allows efcient and stable transgene expression. Am. J. Physiol. Heart Circ. Physiol., 294, H1667-H1674.